Long-term ingestion of a fermented soybean-derived Touchi-extract with alpha-glucosidase inhibitory activity is safe and effective in humans with borderline and mild type-2 diabetes. (Q51547808)
Jump to navigation
Jump to search
scientific article published in August 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term ingestion of a fermented soybean-derived Touchi-extract with alpha-glucosidase inhibitory activity is safe and effective in humans with borderline and mild type-2 diabetes. |
scientific article published in August 2001 |
Statements
1 reference
Long-term ingestion of a fermented soybean-derived Touchi-extract with alpha-glucosidase inhibitory activity is safe and effective in humans with borderline and mild type-2 diabetes. (English)
1 reference
H Fujita
1 reference
T Yamagami
1 reference
K Ohshima
1 reference
1 August 2001
1 reference
131
1 reference
8
1 reference
2105-2108
1 reference
1 reference
Identifiers
1 reference